This contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is for the delivery of the drug Pulmozyme, a medication used to treat cystic fibrosis. The award, valued at $25,335.45, is a Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has a performance period through November 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is likely part of that broader IDC, enabling efficient government procurement of essential medications to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/19/25, 9:26 AM